1. Home
  2. TRMK vs PGEN Comparison

TRMK vs PGEN Comparison

Compare TRMK & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Trustmark Corporation

TRMK

Trustmark Corporation

HOLD

Current Price

$46.18

Market Cap

2.7B

Sector

Finance

ML Signal

HOLD

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$7.42

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRMK
PGEN
Founded
1889
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.2B
IPO Year
1994
2013

Fundamental Metrics

Financial Performance
Metric
TRMK
PGEN
Price
$46.18
$7.42
Analyst Decision
Hold
Buy
Analyst Count
2
5
Target Price
$44.50
$8.33
AVG Volume (30 Days)
317.9K
6.1M
Earning Date
04-28-2026
05-13-2026
Dividend Yield
2.26%
N/A
EPS Growth
1.93
N/A
EPS
2.03
0.03
Revenue
N/A
$230,981,000.00
Revenue This Year
$9.82
$1,115.92
Revenue Next Year
$4.86
$81.04
P/E Ratio
$22.71
$242.67
Revenue Growth
N/A
N/A
52 Week Low
$36.33
$2.99
52 Week High
$49.00
$7.55

Technical Indicators

Market Signals
Indicator
TRMK
PGEN
Relative Strength Index (RSI) 41.47 67.89
Support Level $45.10 $3.96
Resistance Level $46.34 N/A
Average True Range (ATR) 0.68 0.40
MACD -0.26 0.03
Stochastic Oscillator 18.48 95.38

Price Performance

Historical Comparison
TRMK
PGEN

About TRMK Trustmark Corporation

Trustmark Corp is a bank holding company. Through its subsidiaries, the company operates as a financial services organization providing banking and other financial solutions in Alabama, Florida, Mississippi, Tennessee, and Texas. Its principal products and services include Commercial Banking, Consumer Banking, Mortgage Banking, Insurance, Wealth Management and Trust Services, and others. The company is managed along two operating segments: General Banking and Wealth Management. The General Banking segment, which generates the majority of the revenue, provides all traditional banking products and services, including loan deposits, and also consists of internal operations.

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

Share on Social Networks: